In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| 8-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
REIT Advisory | | 74.6 | 70.2 | 84.7 | 91.9 | 68.9 | | |
Ashford Trust OP | | | | | | | 51.0 | |
Premier | | 12.4 | 11.6 | 30.6 | 10.6 | | | |
Corporate and Other | | 24.0 | 17.0 | 7.7 | 10.9 | 3.2 | | |
Other | | 273.5 | 194.6 | 164.0 | 82.2 | 9.5 | 16.6 | |
Total revenues [+] | 644.4 | 384.6 | 293.4 | 287.0 | 195.5 | 81.6 | 67.6 | 59.0 |
Reimbursements | 361.4 | 204.0 | 158.5 | 80.4 | 44.3 | 20.9 | | |
Other | 44.3 | | | | | | | 0.4 |
Revenue growth [+] | 67.6% | 31.1% | 2.2% | 46.8% | 139.7% | 20.7% | 14.6% | 241.2% |
REIT Advisory | | 6.3% | -17.2% | -7.8% | 33.4% | | | |
Premier | | 7.0% | -62.1% | 187.6% | | | | |
Corporate and Other | | 41.5% | 119.3% | -28.7% | 238.1% | | | |
OpenKey | | 32.9% | 49.8% | -1.2% | 205.5% | | | |
Cost of goods sold | 73.0 | 65.3 | 57.2 | 59.7 | 45.3 | 49.3 | 52.4 | 41.4 |
Gross profit | 571.4 | 319.3 | 236.2 | 227.4 | 150.2 | 32.2 | 15.2 | 17.5 |
Gross margin | 88.7% | 83.0% | 80.5% | 79.2% | 76.8% | 39.5% | 22.4% | 29.7% |
Selling, general and administrative [+] | 33.5 | 26.3 | 20.4 | 33.5 | 27.6 | 8.9 | 16.5 | 18.1 |
General and administrative | 33.5 | 26.3 | 20.4 | 33.5 | 27.6 | 8.9 | 16.5 | 18.1 |
Equity in earnings | 0.4 | -0.1 | 0.2 | -0.3 | | | | |
Other operating expenses | 516.4 | 264.5 | 211.0 | 180.6 | 113.7 | 30.8 | | |
EBITDA [+] | | 34.3 | 10.8 | 19.6 | 14.4 | -6.5 | -1.3 | -0.6 |
EBITDA growth | -35.9% | 217.8% | -45.0% | 36.4% | -320.9% | 407.6% | 132.4% | -98.8% |
EBITDA margin | 3.4% | 8.9% | 3.7% | 6.8% | 7.4% | -8.0% | -1.9% | -0.9% |
Depreciation | | 12.9 | 18.0 | 15.0 | 8.0 | 2.8 | 1.2 | 0.8 |
EBITA | 22.0 | 21.4 | -7.2 | 4.6 | 6.4 | -9.3 | -2.5 | -1.4 |
EBITA margin | 3.4% | 5.6% | -2.4% | 1.6% | 3.3% | -11.4% | -3.6% | -2.3% |
Amortization of intangibles | | 25.6 | 27.7 | 16.1 | 5.3 | 0.2 | | |
EBIT [+] | 22.0 | -4.2 | -34.9 | -11.5 | 1.1 | -9.5 | -2.5 | -1.4 |
EBIT growth | -623.6% | -88.0% | 202.9% | -1166.3% | -111.4% | 284.6% | 81.9% | -97.1% |
EBIT margin | 3.4% | -1.1% | -11.9% | -4.0% | 0.6% | -11.6% | -3.6% | -2.3% |
Non-recurring items [+] | | 1.2 | 188.8 | | 1.9 | 1.1 | | |
Asset impairment | | 1.2 | 188.8 | | 1.9 | 1.1 | | |
Interest expense, net [+] | 9.6 | 4.9 | 5.4 | 2.0 | 0.6 | -0.2 | -0.1 | -0.4 |
Interest expense | 10.0 | 5.1 | 5.4 | 2.1 | 1.0 | 0.1 | | |
Interest income | 0.4 | 0.3 | 0.0 | 0.0 | 0.3 | 0.2 | 0.1 | 0.4 |
Other income (expense), net [+] | -0.9 | -0.8 | -1.0 | -0.3 | -1.1 | -0.1 | -9.2 | -9.0 |
Amortization of financing costs and debt discount | | -0.3 | -0.3 | -0.3 | -0.2 | 0.0 | | |
Gain (loss) on investments | -0.1 | | | | | | | |
Other non-ooperating expenses | | | | | | | -0.2 | -0.2 |
Other | -25.8 | -0.4 | -0.3 | 0.0 | -0.8 | -0.1 | -0.2 | -0.2 |
Pre-tax income | 11.5 | -11.0 | -230.0 | -13.8 | -2.5 | -10.5 | -11.6 | -10.0 |
Income taxes | 8.5 | -0.2 | -14.3 | 1.5 | -10.4 | 9.7 | 0.8 | 2.1 |
Tax rate | 74.5% | 1.5% | 6.2% | | 407.4% | | | |
Minority interest | | 0.7 | 1.2 | 0.5 | 0.9 | | | |
Net income | 3.6 | -46.0 | -247.3 | -30.2 | 5.0 | -18.4 | -2.4 | -12.0 |
Net margin | 0.6% | -12.0% | -84.3% | -10.5% | 2.6% | -22.5% | -3.5% | -20.4% |
|
Basic EPS [+] | $1,250.77 | ($16.68) | ($108.30) | ($12.51) | $2.30 | ($9.04) | ($1.19) | ($6.05) |
Growth | -7597.3% | -84.6% | 765.8% | -644.3% | -125.4% | 658.8% | -80.3% | -74.9% |
Diluted EPS [+] | $1,250.77 | ($16.68) | ($108.30) | ($4.00) | $2.14 | ($8.88) | ($1.08) | ($5.47) |
Growth | -7597.3% | -84.6% | 2606.5% | -287.1% | -124.1% | 718.6% | -80.2% | -77.3% |
|
Shares outstanding (basic) [+] | 0.0 | 2.8 | 2.3 | 2.4 | 2.2 | 2.0 | 2.0 | 2.0 |
Growth | -99.9% | 20.7% | -5.5% | 11.3% | 6.8% | 0.9% | 1.1% | 0.5% |
Shares outstanding (diluted) [+] | 0.0 | 2.8 | 2.3 | 7.6 | 2.3 | 2.1 | 2.2 | 2.2 |
Growth | -99.9% | 20.7% | -69.8% | 223.8% | 12.8% | -6.4% | 0.3% | 11.2% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |